Cryoelectrospun elastin-alginate scaffolds as potential cell delivery vehicles for mesenchymal stromal cell therapy
Abstract Salivary gland fibrosis results in salivary hypofunction whose current treatments are palliative. Mesenchymal stem/stromal cells (MSCs) are anti-fibrotic and anti-inflammatory and provide a promising alternative to treat fibrosis, but face translational challenges due to poor tissue targeti...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-06-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-03822-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850138021282709504 |
|---|---|
| author | Pujhitha Ramesh Rafael Pena Jennifer M. Morrissey Nicholas Moskwa Kate Tubbesing Xulang Zhang Deirdre Nelson James Castracane Alexander Khmaladze Susan T. Sharfstein Melinda Larsen Yubing Xie |
| author_facet | Pujhitha Ramesh Rafael Pena Jennifer M. Morrissey Nicholas Moskwa Kate Tubbesing Xulang Zhang Deirdre Nelson James Castracane Alexander Khmaladze Susan T. Sharfstein Melinda Larsen Yubing Xie |
| author_sort | Pujhitha Ramesh |
| collection | DOAJ |
| description | Abstract Salivary gland fibrosis results in salivary hypofunction whose current treatments are palliative. Mesenchymal stem/stromal cells (MSCs) are anti-fibrotic and anti-inflammatory and provide a promising alternative to treat fibrosis, but face translational challenges due to poor tissue targeting and retention. Scaffolds could facilitate targeted MSC delivery and improve MSC retention. Here, we demonstrated the feasibility of using stromal extracellular matrix (ECM)-mimicking elastin-alginate cryoelectrospun scaffolds (CES) for MSC delivery. Using MSC-like primary embryonic salivary mesenchyme cells (SMSCs), we demonstrated that CES supported viable, healthy and non-fibrotic long-term stromal cell maintenance while suppressing the fibrotic phenotype in myofibroblasts. We established an in vitro fibrosis model by coculturing SMSCs and myofibroblasts on CES and validated that SMSCs on CES imparted anti-fibrotic effects on myofibroblasts; however, these effects were suppressed by TGF-β1. In vivo orthotopic implantation of CES and SMSC-CES constructs showed that CES were biocompatible, non-inflammatory, and non-fibrotic, however, they did not remediate fibrosis. Further, supplementation of anti-fibrotic FGF2 to the in vitro fibrosis model demonstrated partial rescue of the anti-fibrotic effects of SMSC-CES constructs on myofibroblasts stimulated by TGF-β1 signaling. These studies set the premise for multi-pronged therapeutic approaches and validate CES as a potential stromal cell delivery vehicle in regenerative medicine applications. |
| format | Article |
| id | doaj-art-a07de943ff8f46ffb933674ecab0fc1a |
| institution | OA Journals |
| issn | 2045-2322 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-a07de943ff8f46ffb933674ecab0fc1a2025-08-20T02:30:41ZengNature PortfolioScientific Reports2045-23222025-06-0115111810.1038/s41598-025-03822-xCryoelectrospun elastin-alginate scaffolds as potential cell delivery vehicles for mesenchymal stromal cell therapyPujhitha Ramesh0Rafael Pena1Jennifer M. Morrissey2Nicholas Moskwa3Kate Tubbesing4Xulang Zhang5Deirdre Nelson6James Castracane7Alexander Khmaladze8Susan T. Sharfstein9Melinda Larsen10Yubing Xie11Department of Nanoscale Science and Engineering, University at Albany, State University of New YorkDepartment of Biological Sciences, University at Albany, State University of New YorkDepartment of Biological Sciences, University at Albany, State University of New YorkDepartment of Biological Sciences, University at Albany, State University of New YorkDepartment of Biological Sciences, University at Albany, State University of New YorkDepartment of Nanoscale Science and Engineering, University at Albany, State University of New YorkDepartment of Biological Sciences, University at Albany, State University of New YorkDepartment of Nanoscale Science and Engineering, University at Albany, State University of New YorkDepartment of Physics, University at Albany, State University of New YorkDepartment of Nanoscale Science and Engineering, University at Albany, State University of New YorkDepartment of Biological Sciences, University at Albany, State University of New YorkDepartment of Nanoscale Science and Engineering, University at Albany, State University of New YorkAbstract Salivary gland fibrosis results in salivary hypofunction whose current treatments are palliative. Mesenchymal stem/stromal cells (MSCs) are anti-fibrotic and anti-inflammatory and provide a promising alternative to treat fibrosis, but face translational challenges due to poor tissue targeting and retention. Scaffolds could facilitate targeted MSC delivery and improve MSC retention. Here, we demonstrated the feasibility of using stromal extracellular matrix (ECM)-mimicking elastin-alginate cryoelectrospun scaffolds (CES) for MSC delivery. Using MSC-like primary embryonic salivary mesenchyme cells (SMSCs), we demonstrated that CES supported viable, healthy and non-fibrotic long-term stromal cell maintenance while suppressing the fibrotic phenotype in myofibroblasts. We established an in vitro fibrosis model by coculturing SMSCs and myofibroblasts on CES and validated that SMSCs on CES imparted anti-fibrotic effects on myofibroblasts; however, these effects were suppressed by TGF-β1. In vivo orthotopic implantation of CES and SMSC-CES constructs showed that CES were biocompatible, non-inflammatory, and non-fibrotic, however, they did not remediate fibrosis. Further, supplementation of anti-fibrotic FGF2 to the in vitro fibrosis model demonstrated partial rescue of the anti-fibrotic effects of SMSC-CES constructs on myofibroblasts stimulated by TGF-β1 signaling. These studies set the premise for multi-pronged therapeutic approaches and validate CES as a potential stromal cell delivery vehicle in regenerative medicine applications.https://doi.org/10.1038/s41598-025-03822-xCryoelectrospinningElastin-alginate scaffoldMSC deliveryFibrosisSalivary glandIn vivo implantation |
| spellingShingle | Pujhitha Ramesh Rafael Pena Jennifer M. Morrissey Nicholas Moskwa Kate Tubbesing Xulang Zhang Deirdre Nelson James Castracane Alexander Khmaladze Susan T. Sharfstein Melinda Larsen Yubing Xie Cryoelectrospun elastin-alginate scaffolds as potential cell delivery vehicles for mesenchymal stromal cell therapy Scientific Reports Cryoelectrospinning Elastin-alginate scaffold MSC delivery Fibrosis Salivary gland In vivo implantation |
| title | Cryoelectrospun elastin-alginate scaffolds as potential cell delivery vehicles for mesenchymal stromal cell therapy |
| title_full | Cryoelectrospun elastin-alginate scaffolds as potential cell delivery vehicles for mesenchymal stromal cell therapy |
| title_fullStr | Cryoelectrospun elastin-alginate scaffolds as potential cell delivery vehicles for mesenchymal stromal cell therapy |
| title_full_unstemmed | Cryoelectrospun elastin-alginate scaffolds as potential cell delivery vehicles for mesenchymal stromal cell therapy |
| title_short | Cryoelectrospun elastin-alginate scaffolds as potential cell delivery vehicles for mesenchymal stromal cell therapy |
| title_sort | cryoelectrospun elastin alginate scaffolds as potential cell delivery vehicles for mesenchymal stromal cell therapy |
| topic | Cryoelectrospinning Elastin-alginate scaffold MSC delivery Fibrosis Salivary gland In vivo implantation |
| url | https://doi.org/10.1038/s41598-025-03822-x |
| work_keys_str_mv | AT pujhitharamesh cryoelectrospunelastinalginatescaffoldsaspotentialcelldeliveryvehiclesformesenchymalstromalcelltherapy AT rafaelpena cryoelectrospunelastinalginatescaffoldsaspotentialcelldeliveryvehiclesformesenchymalstromalcelltherapy AT jennifermmorrissey cryoelectrospunelastinalginatescaffoldsaspotentialcelldeliveryvehiclesformesenchymalstromalcelltherapy AT nicholasmoskwa cryoelectrospunelastinalginatescaffoldsaspotentialcelldeliveryvehiclesformesenchymalstromalcelltherapy AT katetubbesing cryoelectrospunelastinalginatescaffoldsaspotentialcelldeliveryvehiclesformesenchymalstromalcelltherapy AT xulangzhang cryoelectrospunelastinalginatescaffoldsaspotentialcelldeliveryvehiclesformesenchymalstromalcelltherapy AT deirdrenelson cryoelectrospunelastinalginatescaffoldsaspotentialcelldeliveryvehiclesformesenchymalstromalcelltherapy AT jamescastracane cryoelectrospunelastinalginatescaffoldsaspotentialcelldeliveryvehiclesformesenchymalstromalcelltherapy AT alexanderkhmaladze cryoelectrospunelastinalginatescaffoldsaspotentialcelldeliveryvehiclesformesenchymalstromalcelltherapy AT susantsharfstein cryoelectrospunelastinalginatescaffoldsaspotentialcelldeliveryvehiclesformesenchymalstromalcelltherapy AT melindalarsen cryoelectrospunelastinalginatescaffoldsaspotentialcelldeliveryvehiclesformesenchymalstromalcelltherapy AT yubingxie cryoelectrospunelastinalginatescaffoldsaspotentialcelldeliveryvehiclesformesenchymalstromalcelltherapy |